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The heavy and light chains of botulinum Atoxin were separated by anion exchange chromatography. Their intracellular 
actions were studied using bovine adrenal chromaffin cells penneabi1ized with streptolysin O. Purified light chain inhibited 
the Caz + -stimulated pH]noradrenaline release with a half-maximal effect at about 1.8 nM. The inhibition was incomplete. 
Heavy chain up to 28 nM was neither effective by itself nor did it enhance the inhibitory effect of light chain. It is con-
cluded that the light chain of botulinum A toxin contains the functional domain responsible for the inhibition of exocyto-
sis. 
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1. INTRODUCTION 
Botulinum Atoxin (Botx A) belongs to the ex-
tremely poisonous clostridial neurotoxins [1,2]. 
The 150 kDa protein consists of a heavy chain 
(100 kDa) and a light chain (50 kDa) covalently 
linked by a disulfide bond. It inhibits transmitter 
release from neurons [1,2] as weIl as catecholamine 
release from adrenal chromaffin cells [3,4]. Direct 
application into the cytosol of adrenal chromaffin 
cells either by injection [5] or through large pores 
in the plasma membrane [6] confirmed that Botx A 
attacks a step during exocytosis common to 
neurons and chromaffin cells. 
The inhibition of catecholamine release by both 
tetanus toxin and Botx A is increased in the 
presence of a reducing agent [6,7]. This observa-
tion indicates that the disulfide bond linking the 
two chains in the clostridial neurotoxins has to be 
cleaved during their activation. Indeed the action 
of tetanus toxin is due to its light chain whereas its 
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heavy chain has no effect [8]. In the present study 
we prepared and used the heavy and light ehains of 
Botx A to find out which part of the molecule af-
feets exoeytosis and whether Botx A is activated in 
the cell by a mechanism similar to that proposed 
for tetanus toxin [8}. 
2. MATERIALS AND METHODS 
2.1. Materials 
Botx A (two chain form) as obtained from Batelle Institute 
Frankfurt, FRG, was homogeneous in SDS gel electrophoresis. 
It was separated into its heavy and light chain by HPLC anion 
exchange chromatography using a modification of an LPLC 
procedure as described earlier [9]. All steps were performed at 
18°C at pH 8.4 (adjusted with NaOH). Typically 600 pg (1 ml) 
Botx A were first desalted on an Econo-Pac IOGD (Bio-Rad) 
column and then applied to a Mono Q 5/5 (Pharmacia-LKB) 
column both equilibrated with buffer A containing (mM): 
NazB407 7.5 and NaHZP04 15. The Mono Q column was wash-
ed with 6 ml of buffer A. For chain separation 50 mM 
dithiothreitol (DTT) dissolved in 1.5 ml of buffer A was ~pplied 
to the column and the flow stopped for 2 h. Then the light chain 
was eluted at a rate of 0.25 ml/min with 7.5 ml of a mixture of 
9 parts buffer B (buffer A supplemented with 2 M urea and 
50 mM DTT) and one part of buffer C containing (mM): 
Nazli407 75, NaHzP04 150, urea 2000, DTT 50. The absorbed 
heavy chain was finally eluted from the column with 7.5 ml of 
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buffer C. Fractions were collected and the chains were localized 
using a protein assay (10). Immediately after separation the 
chains were dialyzed against KG buffer I containing (mM): K+ 
glutamate 150, Pipes 10, EGTA 0.5, NTA 5, pH 7.2 sup-
plemented with I or 5 mM OTT. Toxicity (LOso, s.c. in mice) 
was I ng/kg for the two chain form and between I and 5 ,ttg/kg 
for the separated heavy or light chains, respective1y. Botulinum 
A antitoxin, an immune serum from horse containing 
750 lU/mi was obtained from Behring Werke Marburg, FRG; 
and dialyzed against KG-buffer I before use. Streptolysin 0 
(SLO) was purified [11); it was kindly provided by S. Bhakdi 
(Giessen). The activity of SLO, routinely checked using 2.5OJo 
rabbit erythrocytes, is given in hemolytic units (HÜ/ml) (12). 
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Fig.I. Specificity of the inhibitory effect of Botx A light chain 
on Ca2+ stimulated [3H)noradrenaline release from 
permeabilized chromaffin cells. (A) Permeabilized adrenal 
chromaffin cells were incubated with KG-buffer (see section 2), 
5 nM Botx A two chain form (T.C.), 5 nM Botx A light chain 
(L.C.), 5 nM Botx A heavy chain (H.C.) or a combination of 
5 nM heavy plus 5 nM light chain for 25 min at 37°C. Then 
they were stimulated for 10 min with fresh KG-buffer 
containing 30 pM free Ca2+. Release in the absence of Caz+ 
(3.9 ± 0.2) was subtracted. (B) Prior to the addition of Ca2+ 
(30 pM free) the permeabilized cells were incubated for 25 min 
at 37°C with KG-buffer, 5 nM light chain, or 7.51U/ml 
botulinum A antitoxin {AT) or 5 nM light chain plus 7.5 IUlml 
AT. All additives were kept for 2 h at room temperature before 
use. Release in the absence of Caz+ (3.6 ± 0.3) was subtracted. 
Values are the mean of 3 sampies ± SO. 
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2.2. Methods 
Chromaffin cells from bovine adrenal medulla were prepared 
and kept in short-time cultures as described ([6), for review see 
[13]). After pre10ading the cells with tritiated noradrenaline 
they were permeabilized with SLO (60 HU/ml) for 2 min at 
37°C (12) and incubated between 5 and 25 min with the respec-
tive toxin preparation dissolved in KG buffer II (KG-buffer I 
containing additional 2 mM Mg2+ IA TP complex and I mM 
free Mgz+) suppiemented with O.IOJo BSA and 1 mM OTT. 
Finally the cells were stimulated with fresh KG buffer II con-
taining micromolar amounts of free Caz+ for 10 min [6,12). 
Free Caz+ concentrations were calculated using the stability 
constants given (14) and were routinely monitored by a 
Caz+-sensitive e1ectrode (15). 
3. RESULTS 
Ca2 + -induced catecholamine release from SLO-
permeabilized adrenal medullary chromaffin cells 
in primary culture is affected by the two chain 
form of Botx A (5 nM) in the presence of 1 mM 
DTT (fig.lA and [6]). When given alone the light 
chain (5 nM) inhibited Ca2 + induced exocytosis 
from permeabilized adrenal chromaffin cells, 
whereas the same amount of heavy chain was inef-
fective (fig.lA). The equimolar mixture of the 
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Fig.2. Time course of the inhibitory action of Botx A light chain 
on Caz+ -stimulated [3H)noradrenaline release. Permeabilized 
adrenal chromaffin cells were incubated for 25 min in KG-
buffer II (see section 2.2) supplemented with O.IOJo BSA and 
I mM OTT. Botx A light chain (5 nM) (closed symbols) was 
present either from the beginning or added 15 min or 5 min 
before the buffer was replaced by a fresh one containing either 
no or 30,ttM free Caz+. Controls (with no light chain added, 
open symbols) were treated similarly. Values represent the Caz+ 
stimulated release of 3 sampies ± SO. Release in the absence of 
Caz+ (4.0 ± 0.7 for controls and 4.1 ± 0.2 for light chain 
present for 25 min) was subtracted. Values are the mean of 3 
sampies ± SO. 
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heavy and the light chain was rather less effective 
than the separated light chain alone (fig.IA, see 
also fig.3). The inhibitory action of the light chain 
was prevented by preincubation with antitoxin in-
dicating its specific action. The antitoxin itself did 
not modify exocytosis from the permeabilized 
chrom affin cells (fig.IB). 
The inhibitory action of the light chain increased 
with the incubation time as previously shown for 
the two chain toxin [6]. The light chain was present 
either for 5, 15, or 25 min prior to the stimulation 
with Ca2+. A slight inhibition of exocytosis was 
observed during 5 min presence of light chain, 
which increased to about 50070 after 25 min. Even 
when present during the whole incubation period 
the light chain did not alter the basal release 
(fig.2). 
The inhibitory action of Botx A light chain was 
always incomplete. It started already below 1 nM, 
was maximal with doses over 5 nM and half max-
imal at 1.8 ± 1.2 nM (SD; n = 4). The presence of 
28 nM Botx A heavy chain did not add to the in-
hibitory action caused by the light chain. Indeed 
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Fig.3. Dose-response curve of the inhibitory action of Bou A 
light chain on exocytosis in the absence or presence of its heavy 
chain. Permeabilized adrenal chromaffin cells were incubated 
for 25 min at 37°C in KG buffer 11 with increasing amounts of 
light chain (abscissa). The buffer was replaced with fresh buffer 
either with or without 30 pM free Ca2+ and cells were further 
incubated for 10 min. The values represent the Ca2+ stimulated 
release. The effects of Botx A light chain in the absence (open 
symbols) or presence (closed symbols) of 28 nM Botx A heavy 
chain are shown. Controls were also run in the absence or 
presence of heavy chain. Values (mean of two sampIes) in the 
absence of Ca2+ (3.4/3.8 for controls and 3.6/3.7 for 28 nM 
heavy chain) were subtracted. Note that Bou A heavy chain did 
not substantially alter the Ca2+ stimulated release. 
rather a slight reduction of the efficacy of the light 
chain was observed (fig.3, see also fig.1A). 
4. DISCUSSION 
The results reported here indicate that the light 
chain of Botx A contains the functional domain 
responsible for the intracellular inhibition of exo-
cytosis. Addition of heavy chain rather inhibits 
than prornotes the inhibitory effect. As already 
shown for tetanus toxin in Aplysia neurons [16] 
and chromaffin cells [8], inhibition of exocytosis 
due to Botx A can be mimicked by its light chain. 
The fact that only part of their molecules is re-
quired to elicit the intracellular effects adds the 
clostridial neurotoxins to a group comprising 
cholera toxin [17], diphtheria toxin [18], pertussis 
toxin [19] and the botulinum toxin C2 [20]. In these 
toxins a larger subunit mediates binding and pro-
motes internalization whereas a smaller compo-
nent is an enzyme which affects various 
intracellular processes. However, any enzymatic 
activity of the light chain of either Botx A or 
tetanus toxin is still to be found. 
The action of the Botx A light chain in chromaf-
fin cells differs from that in Aplysia neurons. Here 
both the heavy and the light chain of Botx A must 
be present to inhibit transmitter release [21J 
whereas in chromaffin cells the action of Botx A 
light chain is independent of the heavy chain (this 
study). On the other hand the light chain of tetanus 
toxin alone is fully active in both Aplysia neurons 
[16) and adrenal chromaffin cells [8]. The dif-
ferences may be caused by the chemical instability 
of the Botx A light chain. When given alone it 
might quickly lose its activity in the high osmolar 
medium required for the Aplysia neurons. Addi-
tion of the heavy chain may stabilize the light chain 
which then inhibits exocytosis. 
The modes of action of tetanus toxin and 
botulinum Atoxin are not strictly identical. This is 
true for the neuromuscular junction of the mouse 
hemidiaphragm [22] and for adrenal chromaffin 
cells [6,8]. Thus Botx A but not tetanus toxin may 
attack a step during exocytosis which is different in 
neurons as compared to chromaffin cells. 
Further studies using endocrine cells and mam-
malian neurons will be necessary to shed light on 
the pharmacokinetics and pharmacodynamics of 
clostridial neurotoxins at the cellular level. 
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